Aditi K Chaudhary
-
Venus Remedies secures regulatory approvals for three key oncology drugs in Ukraine
Ukrainian has given marketing approvals for paclitaxel, oxaliplatin and irinotecan Venus Remedies has further expanded the reach of its oncology…
Read More » -
Venus Remedies secures marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia Venus Remedies, a global leader in…
Read More » -
Venus Remedies bags marketing authorisation for enoxaparin from Azerbaijan
Azerbaijan’s pharmaceutical market is import-dominated, with India accounting for 4-5 per cent of the total pharmaceutical imports Venus Remedies, a…
Read More » -
Venus Remedies bags marketing approvals from Philippines, Saudi Arabia for three drugs
While Saudi Arabia is the largest pharmaceutical market in GCC region, Philippines happens to be the second largest market in…
Read More » -
Venus Remedies launches flagship R&D drug Elores in Oman
The company is targeting the $237-million antibiotic market in the GCC region, out of which 35 per cent accounts for…
Read More »